ONGOING PHASE 1/2 STUDY OF INCB050465, A SELECTIVE PI3Kδ...

Hematological Oncology 2017 / 06 Vol. 35

ONGOING PHASE 1/2 STUDY OF INCB050465, A SELECTIVE PI3Kδ INHIBITOR, FOR THE TREATMENT OF PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES (CITADEL-101)

Caimi, P., Ramchandren, R., Phillips, T.J., Wertheim, M.S., Gutierrez, M.E., Edenfield, W.J., Akard, L.P., Call, J.A., Persky, D.O., DeMarini, D.J., Zhou, L., Yeleswaram, S., Forero-Torres, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2438_139
Date:
June, 2017
File:
PDF, 74 KB
english, 2017
Conversion to is in progress
Conversion to is failed